Q2 FY2026 EarningsQ2 FY26 revenue of $13.2M missed the mean consensus of $15.1M but sat at the high end of the $12.7M–$13.2M analyst range. Gross margin of 55.6% significantly beat the mean consensus of 49.4% due to Focal One cost reductions. While EPS GAAP of -$0.38 missed the -$0.22 mean expectation, this was largely driven by a non-cash $5.5M fair value adjustment on EIB warrants. Strategic focus shifted exclusively to the HIFU business following the discontinuation of ESWL and Distribution segments.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: EDAP TMS(FOCL) the Revenue is 13.2 M (-29.1%), Miss estimate;the EBIT is -8.033 M (-19.96%), Miss estimate;the EPS is -0.39 (-124%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.01B29.10%
0.02B19.04%
-0.00B10.06%
EBITMiss expectations
-0.01B19.96%
-0.01B9.95%
-0.00B29.91%
EPSMiss expectations
-0.39123.98%
-0.22428.65%
-0.166095.33%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf